Treating inflammation by blocking interleukin-1 in humans.
about
Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?Questions and controversies in innate immune research: what is the physiological role of NLRP3?The complex cascade of cellular events governing inflammasome activation and IL-1β processing in response to inhaled particlesThe dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γCrosstalk between the heart and peripheral organs in heart failureOld and new treatment targets in axial spondyloarthritisBasic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of DiseaseNew Insights Into Tissue Macrophages: From Their Origin to the Development of MemoryDysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advancesInternational Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and diseaseEvasion of inflammasome activation by microbial pathogensGout increases risk of fracture: A nationwide population-based cohort study.Different Regulation of Interleukin-1 Production and Activity in Monocytes and Macrophages: Innate Memory as an Endogenous Mechanism of IL-1 Inhibition.The Therapeutic Role of Interleukin-1 Inhibition in Idiopathic Recurrent Pericarditis: Current Evidence and Future Challenges.The meteorology of cytokine storms, and the clinical usefulness of this knowledgeDifferential role of pannexin-1/ATP/P2X7 axis in IL-1β release by human monocytes.Biological treatments in Behçet's disease: beyond anti-TNF therapy.Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.An inherited mutation in NLRC4 causes autoinflammation in human and mice.The promotion of functional urinary bladder regeneration using anti-inflammatory nanofibersInterleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesIndependent roles of the priming and the triggering of the NLRP3 inflammasome in the heart.Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivoRole of IL-38 and its related cytokines in inflammationA small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.Adipokines as drug targets in diabetes and underlying disturbances.The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathwayIdentification of potential small molecule allosteric modulator sites on IL-1R1 ectodomain using accelerated conformational sampling method.Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory responseInterleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case reportConformational Sampling and Binding Site Assessment of Suppression of Tumorigenicity 2 EctodomainGeneration and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1.Differences of IL-1β Receptors Expression by Immunocompetent Cells Subsets in Rheumatoid Arthritis.Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial.Differential ASC requirements reveal a key role for neutrophils and a noncanonical IL-1β response to Pseudomonas aeruginosa.Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future NeedsPlasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humansSuppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetesIL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac AllograftsEfficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature.
P2860
Q26738966-3E88FC90-6598-4A40-8A86-4EE9B69335B8Q26739753-111EE14B-A8A3-451D-B59C-8BEF194CB4AEQ26741584-2400B9D2-B215-4946-8633-D6769177B460Q26750987-C45DFB6B-FB49-4AC8-9657-E4AAA505FD60Q26766491-2E1BCF30-437B-4756-BADC-54023D26DE34Q26777906-84757964-30A4-45C8-B2A7-0D50EB47B6A0Q26781862-089185EA-7CBA-4974-A23F-590D3F66EF69Q26786785-860CB3BB-E0E5-41EF-A455-0BB5FDD06929Q28070056-EC94AECE-8F8D-49DC-AAA9-A467FB1CE128Q28081406-2EAC4160-9825-4B8F-84C4-8E476D6C6795Q28082757-99CA6458-726F-4ACD-BBE8-305FE90EE7B0Q33590612-7083F213-6E38-4F18-A16C-2C55965FAEF1Q33774843-B428C1E4-8DA3-4451-9923-84FEAC6CDAE7Q33785735-BC22C053-58D0-495B-8AF5-53AB64ABA5D2Q33867213-7DEE9F05-17E3-4957-801A-B8B3D7731786Q33898939-A1FB5604-2CEE-4433-805B-C972E101FD46Q33908217-68EA0C3D-7416-4F95-BDDF-B143213726DBQ34404386-E16EF5D9-1461-4B83-BCBA-B4A1A2B77CC9Q34447217-BCE02821-1C52-4822-8A28-F89298D62698Q34722403-5370B496-4B97-4FBF-9248-78FFA6F134CFQ35133812-E5AEE4BC-F917-40CD-863F-D4B841DE27BCQ35171781-73280436-5D35-4810-8FF7-B1E4142E8966Q35235365-D50E43EF-966B-4063-A6E0-4CE323252330Q35250392-BF3933C6-EC3A-4961-91D0-79183A89097DQ35350543-1EEACBF5-A014-41F9-900E-8A39E495680CQ35415815-31E822C4-B692-42CB-8A73-64A479B24EE2Q35559391-716B8C4E-9BD9-4840-8FE0-EB1F254EA817Q35565839-458D987E-815F-415C-AF0E-AFCA26B23CCBQ35594870-BD6456E4-DD97-47E1-A2B1-7E6B2D2A99CDQ35831233-1AFBD2C5-18BC-4BCA-9F3B-5BC297B92DEDQ35886682-3B81BC32-236A-4522-BD7A-0DBCA23E9981Q35941258-3E924700-1F79-4E73-AB0D-437E0A69510FQ36089320-64E1132F-FF51-410E-A049-FD0A021DC6E9Q36126508-3331D324-6652-4137-B373-75E47F393A39Q36174565-EFB9ED1A-9517-46A6-B39A-83B4A9336C72Q36191001-5CEF9195-4709-4090-8CCC-463F68E35C89Q36314713-E5D4B9A6-2799-44B8-9496-17E760EEE121Q36399235-4B02F316-C115-4798-8270-7F8DC3BF3F63Q36655827-F73AD7C8-BA8F-49B2-82A5-203EF5ED4129Q36798016-41B84B34-C30F-4E5C-A2D1-4E42DCF57E54
P2860
Treating inflammation by blocking interleukin-1 in humans.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Treating inflammation by blocking interleukin-1 in humans.
@en
Treating inflammation by blocking interleukin-1 in humans.
@nl
type
label
Treating inflammation by blocking interleukin-1 in humans.
@en
Treating inflammation by blocking interleukin-1 in humans.
@nl
prefLabel
Treating inflammation by blocking interleukin-1 in humans.
@en
Treating inflammation by blocking interleukin-1 in humans.
@nl
P2860
P1476
Treating inflammation by blocking interleukin-1 in humans.
@en
P2093
Jos W M van der Meer
P2860
P304
P356
10.1016/J.SMIM.2013.10.008
P577
2013-11-23T00:00:00Z